BTI.H — biOasis Technologies Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for biOasis Technologies, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

	2018 February 28th	2019 February 28th	2020 February 29th	C2021 February 28th	2022 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.59	1.42	0.606	4.08	0.038
Cost of Revenue
Gross Profit	0.122	1.41	0.606	—	—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	5.87	6.28	5.21	4.09	3.62
Operating Profit	-5.28	-4.86	-4.6	-0.008	-3.58
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-5.31	-3.47	-4.06	0.698	-2.96
Net Income After Taxes	-5.31	-3.47	-4.06	0.698	-2.96
Net Income Before Extraordinary Items
Net Income	-5.31	-3.47	-4.06	0.698	-2.96
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-5.31	-3.47	-4.06	0.698	-2.96
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.104	-0.068	-0.065	-0.007	-0.041